← Back to Search

Serotonin-Norepinephrine Reuptake Inhibitor

Intervention for Peripheral Neuropathy

Phase 2
Waitlist Available
Research Sponsored by Southeastern Regional Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Awards & highlights

Study Summary

This study is evaluating whether a drug may help reduce pain for individuals who have chemotherapy.

Eligible Conditions
  • Peripheral Neuropathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 180 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment with respect to duloxetine of the effect of lorcaserin on the Pain Numerical Rating Scale.
Assessment with respect to duloxetine of the effect of lorcaserin on the patient-reported quality of life.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Lorcaserin 10 mg bid
Group II: ControlActive Control1 Intervention
Duloxetine 60 mg qd
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lorcaserin
FDA approved

Find a Location

Who is running the clinical trial?

Southeastern Regional Medical CenterLead Sponsor
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
2019. "Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03812523.
All > Neuropathy > Peripheral Neuropathy
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top